3.0
Oct 20, 2017
Current employee, less than 1 year
Allschwil
Recommend
CEO approval
Business Outlook
Pros
Focus on emerging markets. Multi-cultural. Good compensation and benefits. Sports offer for employees.
Cons
Still mindset of big Pharma. Slow in long-term decision making. Too many troubleshooting situations due to lack of strategy in Operations although a new role was created some time ago. Too much micromanaging and control over the employees.